Da An Gene Co Ltd of Sun Yat-Sen University (002030) - Total Liabilities
Based on the latest financial reports, Da An Gene Co Ltd of Sun Yat-Sen University (002030) has total liabilities worth CN¥1.07 Billion CNY (≈ $156.22 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore net asset momentum of Da An Gene Co Ltd of Sun Yat-Sen Univers to track the company's year-over-year net asset growth rate.
Da An Gene Co Ltd of Sun Yat-Sen University - Total Liabilities Trend (2001–2025)
This chart illustrates how Da An Gene Co Ltd of Sun Yat-Sen University's total liabilities have evolved over time, based on quarterly financial data. See 002030 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Da An Gene Co Ltd of Sun Yat-Sen University Competitors by Total Liabilities
The table below lists competitors of Da An Gene Co Ltd of Sun Yat-Sen University ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
MasterBrand Inc.
NYSE:MBC
|
USA | $1.76 Billion |
|
Generation Development Group Ltd
AU:GDG
|
Australia | AU$5.58 Billion |
|
Genusplus Group Ltd
AU:GNP
|
Australia | AU$311.19 Million |
|
MPC Container Ships ASA
OL:MPCC
|
Norway | Nkr599.75 Million |
|
Varroc Engineering Limited
NSE:VARROC
|
India | Rs30.34 Billion |
|
ChemoMetec A/S
CO:CHEMM
|
Denmark | Dkr130.78 Million |
|
Zhejiang Huangma Technology Co Ltd
SHG:603181
|
China | CN¥927.28 Million |
|
Jingjin Environmental Protection Co Ltd
SHG:603279
|
China | CN¥4.12 Billion |
Liability Composition Analysis (2001–2025)
This chart breaks down Da An Gene Co Ltd of Sun Yat-Sen University's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Da An Gene Co Ltd of Sun Yat-Sen Univers (002030) total market value.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.98 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.15 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.13 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Da An Gene Co Ltd of Sun Yat-Sen University's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Da An Gene Co Ltd of Sun Yat-Sen University (2001–2025)
The table below shows the annual total liabilities of Da An Gene Co Ltd of Sun Yat-Sen University from 2001 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | CN¥1.15 Billion ≈ $167.66 Million |
-20.10% |
| 2024-12-31 | CN¥1.43 Billion ≈ $209.82 Million |
-22.94% |
| 2023-12-31 | CN¥1.86 Billion ≈ $272.30 Million |
-40.76% |
| 2022-12-31 | CN¥3.14 Billion ≈ $459.65 Million |
+17.36% |
| 2021-12-31 | CN¥2.68 Billion ≈ $391.65 Million |
+22.47% |
| 2020-12-31 | CN¥2.19 Billion ≈ $319.79 Million |
+48.25% |
| 2019-12-31 | CN¥1.47 Billion ≈ $215.71 Million |
+0.78% |
| 2018-12-31 | CN¥1.46 Billion ≈ $214.05 Million |
-26.87% |
| 2017-12-31 | CN¥2.00 Billion ≈ $292.68 Million |
+26.07% |
| 2016-12-31 | CN¥1.59 Billion ≈ $232.15 Million |
+43.96% |
| 2015-12-31 | CN¥1.10 Billion ≈ $161.26 Million |
+63.13% |
| 2014-12-31 | CN¥675.55 Million ≈ $98.85 Million |
+70.13% |
| 2013-12-31 | CN¥397.08 Million ≈ $58.11 Million |
+38.80% |
| 2012-12-31 | CN¥286.08 Million ≈ $41.86 Million |
+23.75% |
| 2011-12-31 | CN¥231.17 Million ≈ $33.83 Million |
+20.77% |
| 2010-12-31 | CN¥191.41 Million ≈ $28.01 Million |
+22.25% |
| 2009-12-31 | CN¥156.57 Million ≈ $22.91 Million |
+8.29% |
| 2008-12-31 | CN¥144.59 Million ≈ $21.16 Million |
+23.88% |
| 2007-12-31 | CN¥116.72 Million ≈ $17.08 Million |
+157.16% |
| 2006-12-31 | CN¥45.39 Million ≈ $6.64 Million |
+67.17% |
| 2005-12-31 | CN¥27.15 Million ≈ $3.97 Million |
-51.73% |
| 2004-12-31 | CN¥56.25 Million ≈ $8.23 Million |
-33.31% |
| 2003-12-31 | CN¥84.35 Million ≈ $12.34 Million |
+37.12% |
| 2002-12-31 | CN¥61.51 Million ≈ $9.00 Million |
+25.01% |
| 2001-12-31 | CN¥49.21 Million ≈ $7.20 Million |
-- |
About Da An Gene Co Ltd of Sun Yat-Sen University
Daan Gene Co., Ltd., together with its subsidiaries, researches and develops, manufactures, and sells clinical test reagents, instruments, and supporting consumables in China. It operates through two segments, Biological Products and Related Business and Financial Business. The company offers reagents for hepatitis virus, sexually transmitted infections, blood screening, digestive pathogens, coro… Read more